Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): From the results of phase I and phase II clinical trials

Akihiro Tanimoto, Masumi Kadoya, Yasutaka Kawamura, Ryohei Kuwatsuru, Takehiko Gokan, Shinji Hirohashi

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
JournalAcademic Radiology
Volume9
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this